Xylazine Test Strip Use Among People Who Use Drugs in New York State
- 22 July 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 20 (4) , 392-399
Abstract
Objectives: Xylazine test strips (XTS) allow for rapid identification of xylazine in drugs, yet little is known about those using XTS. Therefore, this study explores the characteristics of people who use drugs (PWUDs) who use XTS and examines risk reduction behaviors associated with XTS use. Methods: This observational cohort study was conducted in New York between September and December 2023 as part of a larger study. Questions about XTS use were added to the parent study’s baseline survey of PWUDs and were completed by 254 PWUDs. Sociodemographic characteristics compared XTS users to nonusers. Propensity score weighting using inverse probability of treatment weights was used to examine the association of ever-using XTS with risk reduction behaviors and the drug type used. Results: Sixty-six participants (26%) had used XTS; 80% trusted the results, and 79% were confident in their ability to use XTS to detect xylazine. Those who had used XTS were more likely to have naloxone nearby (aOR=7.51, 95% CI: 2.26–24.95, P=0.001), use a test shot (aOR=2.43, 95% CI: 1.18–5.01, P=0.016), have someone check on them while using (aOR=2.52, 95% CI: 1.23–5.19, P=0.012), and watch someone use the same drugs (aOR=2.35, 95% CI: 1.19–4.65, P=0.014). XTS use was associated with using opioids (aOR=3.68, 95% CI: 1.38–9.81, P=0.009) and injecting drugs (aOR=4.32, 95% CI: 1.91–9.77, P<0.001). Conclusions: Our study demonstrates that XTS use appears to be associated with engaging in risk reduction behaviors, suggesting XTS can be a useful harm reduction tool. More research is needed to assess whether PWUDs change their drug consumption behaviors based on XTS results.Keywords
This publication has 26 references indexed in Scilit:
- Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use DrugsJAMA Network Open, 2025
- Xylazine in Overdose Deaths and Forensic Drug Reports in US States, 2019-2022JAMA Network Open, 2024
- Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulterationInternational Journal of Drug Policy, 2023
- Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, CaliforniaInternational Journal of Drug Policy, 2023
- Fentanyl preference among people who use opioids in New York CityDrug and Alcohol Dependence, 2022
- Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisisDrug and Alcohol Dependence, 2022
- High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021Clinica Chimica Acta, 2021
- Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programsInternational Journal of Drug Policy, 2021
- The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practicesDrug and Alcohol Dependence, 2020
- Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United StatesInternational Journal of Drug Policy, 2019